News | May 20, 2025
Crosslay Remedies acquires land adjacent to Max Super Speciality Hospital, Vaishali
CRL shall invest another Rs. 200 crore for creation of additional beds
CRL shall invest another Rs. 200 crore for creation of additional beds
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
PAT stood at Rs. 88 crore for Q4 FY25 as compared to Rs. 56 crore in Q4FY24, an increase of 57%
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
IGI recently completed the dose-escalation portion of its Phase 1 clinical study in patients with heavily pretreated multiple myeloma
Topiramate is indicated as a treatment of epilepsy and migraine
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
Trastuzumab specifically binds and inhibits the human epidermal growth factor receptor 2 (HER2) protein
Subscribe To Our Newsletter & Stay Updated
